PADI4 and cancer: Our previous studies established that EV release from cancer cells is largely PAD-driven, can be effectively inhibited using pharmacological PAD inhibitors and that such inhibition sensitizes cancer cells to chemotherapy (Kholia et al., 2015; Kosgodage et al., 2017, 2018).